Keen Vision Acquisition Corp(KVAC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 78.3 | EPS (ttm) | 0.15 | Insider Own | 80.2% | Shs Outstand | 5.5M | Perf Week | - |
| Market Cap | 0.06B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 1.1M | Perf Month | -6.57% |
| Enterprise Value | 0.07B | PEG | - | EPS next Q | - | Inst Own | 21.22% | Short Float | 0.25% | Perf Quarter | -7.62% |
| Income | 0.00B | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 0.18 | Perf Half Y | -2.7% |
| Sales | 0.00B | P/B | 10.95 | EPS next 5Y | - | ROA | 3.37% | Short Interest | 0.00M | Perf YTD | -2.04% |
| Book/sh | 1.05 | P/C | 6338 | EPS past 3/5Y | - | ROE | 3.95% | 52W High | -38.51% ($18.72) | Perf Year | 0.09% |
| Cash/sh | 0 | P/FCF | - | Sales past 3/5Y | - | ROIC | 24.77% | 52W Low | 0.88% ($11.41) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -50.57% | Gross Margin | - | Volatility(W/M) | 15.59% 4.09% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.74 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.02 | EPS Q/Q | -76.76% | Profit Margin | - | RSI (14) | 37.31 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.02 | Sales Q/Q | - | SMA20 | -7.1% ($12.39) | Beta | -0.01 | Target Price | - |
| Payout | - | Debt/Eq | 0.48 | Earnings | - | SMA50 | -5.37% ($12.16) | Rel Volume | 0 | Prev Close | $11.51 |
| Employees | 2 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -0.4% ($11.56) | Avg Volume(3M) | 0.01M | Price | $11.51 |
| IPO | 2023/9/15 | Option/Short | No/No | Trades | 0 | Volume | - | Change | - |
🏢 This is a special purpose acquisition company (SPAC) dedicated to identifying next-generation biotech and healthcare technology companies and bringing them to the public market. It is currently pursuing a merger with a leader in "heart-on-a-chip" technology, which mimics human heart tissue.
Over the past 1 year, on the lower side
39% below its 1-year high.
Traded less than usual. That is 0% of its average volume.
Company yardsticks do not fit here, so profitability, valuation and earnings are left out. The other verdicts still apply.
Long-term returns are roughly flat
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 21.2%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
SPCZ RiverNorth Enhanced Pre-Merger SPAC ETF <0.01% 
RNMN RiverNorth Market Neutral ETF <0.01% It ranks #1312 of 1434 in the industry
Based on market cap of $63M.
SVRN#1307 SVRN Inc $66M PER - 
HFBL#1309 Home Federal Bancorp Inc (Louisiana) $65M PER 10.7 KVAC#1312 Keen Vision Acquisition Corp $63M PER 78.3 
FAQ
What kind of company is KVAC?
KVAC belongs to the Financial sector and operates in the Shell Companies industry.
What is the market cap of KVAC?
The market cap of KVAC is approximately $63M, ranking 4,855 within its sector.
What is the P/E ratio of KVAC?
KVAC has a P/E ratio of approximately 78.3x, which can be used to assess its valuation relative to the Financial sector average.
What is the 52-week high and low for KVAC?
KVAC has recorded a 52-week high of $18.72 and a low of $11.41.
